Trades on 2 secondary markets

Beacon Biosignals

Beacon Biosignals develops AI-powered neurotechnology for brain health, applying machine learning to EEG (electroencephalography) data at scale. Its platform serves two markets: precision neuroscience for drug development, where it collects and analyzes EEG across the clinical trial lifecycle (2M+ h

minimal 14.8 / 100 0 APIs View provider profile →

Company Life Sciences Neurotechnology EEG Sleep Clinical Trials

Beacon Biosignals is an API provider whose private shares are listed on 2 secondary markets: Forge Global, EquityZen.

Where It Trades

F Forge Global View listing → EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.